Anti-Human β-Amyloid Precursor Protein (AβNT) (APP)

Leinco Technologies
Product Code: LEI-A162
Product Group: Primary Antibodies
CodeSizePrice
LEI-A162-20ug20 ug£221.00
Quantity:
LEI-A162-0.1mg0.1 mg£574.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Rabbit
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species: Human
Applications:
  • Immunohistochemistry- Paraffin Embedded (IHC-P)
  • Western Blot (WB)
Shipping:
Ambient
Storage:
This polyclonal antibody is stable for at least one week when stored at 2-8°C. For long term storage aliquot in working volumes without diluting and store at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.

Further Information

Concentration:
0.5 mg/ml
Conjugate/Tag/Label:
Purified No Carrier Protein
Format:
This polyclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.4 containing 0.02% sodium azide as a preservative.
Formulation:
This polyclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.4 containing 0.02% sodium azide as a preservative.
Immunogen:
PN:A280
Long Description:
Accumulation of the amyloid-β peptide (αβ) in the cerebral cortex is a critical event in the pathogenesis of Alzheimer's disease. The b-amyloid protein precursor (APP) is cleaved by β-secretase, producing a soluble derivative of the protein and a membrane anchored 99-amino acid carboxy-terminal fragment (C99). The C99 fragment serves as substrate for g-secretase to generate the 4 kDa amyloid-b peptide (αβ), which is deposited in the brains of all suffers of Alzheimer's disease.
NCBI Gene:
351
Target:
β-Amyloid Precursor Protein

References

1. Ponte, P. et al. (1988) Nature 331:525 2. Selkoe, D. J. (1994) Annu. Rev. Cell Biol. 10:373

Related Products

Product NameProduct CodeSupplier 
Anti-Human β-Amyloid Precursor Protein (CT) (APP)LEI-A163Leinco Technologies Summary Details
β-Amyloid Precursor Protein (AβNT) Blocking PeptideLEI-A280Leinco Technologies Summary Details
β-Amyloid Precursor Protein (CT) Blocking PeptideLEI-A281Leinco Technologies Summary Details